MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47

46Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Immunoevasion is a hallmark of cancer progression, and immune checkpoint blockade has emerged as a promising strategy for cancer treatment. microRNAs (miRNAs) are important negative regulators of gene expression in the immune system. Here, we demonstrate that miR-708 regulates CD47, a transmembrane protein that inhibits phagocytosis in T cell acute lymphoblastic leukemia. miR-708 directly targeted CD47 through binding to 3'UTR and is inversely correlated with CD47 expression. Functional studies showed that restoration of miR-708 expression in the T-ALL cell line is sufficient to promote phagocytosis by macrophages in the absence or presence of the anti-CD47 antibody to eradicate T-ALL cells, and inhibited tumor engraftment in vivo. Together, our findings suggest that miR-708 is a key negative regulator of CD47 and may serve as an attractive candidate for immunotherapy of T-ALL.

Cite

CITATION STYLE

APA

Huang, W., Wang, W. T., Fang, K., Chen, Z. H., Sun, Y. M., Han, C., … Chen, Y. Q. (2018, January 24). MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47. Molecular Cancer. BioMed Central Ltd. https://doi.org/10.1186/s12943-018-0768-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free